Autoimmune Diseases  >>  H.P. Acthar Gel (repository corticotropin injection)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt
NCT02574962: Pilot Study of Acthar® Gel in Chronic Inflammatory Demyelinating Neuropathy

Withdrawn
2
0
US
H.P. Acthar® Gel, Acthar® Gel, repository corticotropin injection
Mamatha Pasnoor, MD, Mallinckrodt
Chronic Inflammatory Demyelinating Polyneuropathy
07/18
07/18
NCT01093157: A Dose Escalation Study of Long-acting ACTH Gel in Membranous Nephropathy

Completed
1/2
10
Canada
Adrenocorticotrophic hormone ACTH, HP Acthar gel
University Health Network, Toronto, Mallinckrodt
Glomerulonephritis
01/13
02/13

Download Options